Financhill
Back

Poseida Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
45

PSTX
Poseida Therapeutics

Last Price:
2.75
Seasonality Move:
20.58%
Sell
33

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
45
Poseida Therapeutics (PSTX) is a Sell

Is Poseida Therapeutics a Buy, Sell or Hold?

  • The current Poseida Therapeutics [PSTX] share price is $2.76. The Score for PSTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PSTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSTX Stock Price Chart

What is Poseida Therapeutics's stock price today?

  • The Poseida Therapeutics share price today is $2.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTX is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

PSTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 47.72 Sell
Chaikin Money Flow: -623533 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.33 - 3.09) Buy
Bollinger Bands (100): (2.58 - 3.32) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53.49 Buy
Chaikin Money Flow: -8154 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.74) Buy
Bollinger Bands (100): (0.27 - 1.57) Sell

PSTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.18 Sell
20-day SMA: 2.75 Buy
50-day SMA: 2.81 Sell
200-day SMA: 2.98 Sell
8-day EMA: 3.08 Sell
20-day EMA: 2.89 Sell
50-day EMA: 2.83 Sell
200-day EMA: 2.91 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.68 Buy
50-day SMA: 0.64 Buy
200-day SMA: 2.44 Sell
8-day EMA: 0.72 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.74 Sell
200-day EMA: 5.82 Sell

Poseida Therapeutics Earnings Growth & PSTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $1.08 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Poseida Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):